Testing a new medicine in people with liver problems
This study tests a new medicine called Y-3 in people with mild or moderate liver problems and in healthy volunteers. It aims to see how the body handles the drug, so doctors can learn the right dose for people with liver issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You need to weigh at least 50 kg (men) or 45 kg (women) and have a BMI between 18 and 30.
- You must have either mild or moderate liver problems (like from hepatitis or cirrhosis) or healthy liver function.
- Your kidney function must be normal (a simple blood test can check this).
- You cannot have taken certain medications or consumed alcohol, grapefruit, or heavy caffeine in the weeks before the study.
- You must be willing to use strict birth control during the trial and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This study tests how food affects the way a new medicine (Y-4 tablet) is processed in the body. It is looking for healthy volunteers to take a single dose of the study drug and have their blood levels checked over time.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
Hear when a new Pharmacokinetic Differences trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.